Neofact® - Medical device for surfactant application

Product description

Neofact is an innovative applicator for instillation of surfactant and is used for the management of respiratory distress syndrome (RDS) in preterm and term neonates:

Simple and practical handling

Application of surfactant without Magill forceps

Precise positioning in front of the glottis

About Neofact:

Medical device class IIa
CE certified
55 cm catheter
3.5 FR catheter

Watch a video on the use of Neofact here: https://www.lyomark.com/neofact/

Specifications

Categories	Pharmaceutical Machinery & TechnologyMedical Devices
Sales markets	Europe - EU countries
Supplied from	Germany

More products from Lyomark Pharma GmbH

Alveofact® - Natural bovine lung surfactant

Alveofact is used in neonates. Preventive use in premature neonates with a high risk of respiratory distress syndrome (RDS).
Active substance: Phospholipid fractionfrom bovine lung (surfactant)

More info

Neofact - Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

Neofact, by Lyomark Pharma, is a medical device for neonates suffering from RDS.
This study shows that the LISA method (less invasive surfactant administration) via Neofact® appears feasible.

Neofact® makes surfactant application easy and is also suitable for all gestatio...

More info

NeoKay® - Vitamin K1 prophylaxis

NeoKay® is a medicinal product used for the prophylaxis of vitamin K1 deficiency bleeding in healthy infants from the 36th week of gestation.
Each soft capsule contains 1 mg phytomenadione (vitamin K1).

Pack sizes of 12s (retail) and 100s (hospital) are available.

...

More info